Savara Announces Encore Presentation of Results From the Phase 3 Impala-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (Apap) at the British Thoracic Society Winter Meeting 2024
Savara宣佈將在2024年英國胸科學會冬季會議上重新呈現Molgramostim吸入溶液（Molgramostim）在自身免疫性肺泡蛋白沉積症（Apap）患者中的3期Impala-2試驗結果
